Programme

 

Overview Sat 1 April Sun 2 April Mon 3 April Tue 4 April Wed 5 April Posters

Tuesday 4 April 2006

   

07.15-08.00

Meet the Expert 9: Medical management of Cushing's disease

   

CLYDE AUDITORIUM

   

Chair: J Newell Price (Sheffield, UK)

   

G Chrousos (Athens, Greece)

     
 

07.15-08.00

Meet the Expert 10: Graves' ophthalmopathy

   

LOMOND AUDITORIUM

   

Chair: P Perros (Newcastle upon Tyne, UK)

   

W Wiersinga (Amsterdam, The Netherlands)

     
 

07.15-08.00

Meet the Expert 11: Metabolic, functional and oncologic consequences of altered GH/IGF expression

   

HALL 1

   

Chair: G Brockman (Berlin, Germany)

   

P Jenkins (London, UK)

     
 

07.15-08.00

Meet the Expert 12: Growth hormone deficiency in adults

   

FORTH ROOM

   

Chair: D Johnston (London, UK)

   

E-M Erfurth (Uppsala, Sweden)

     
 

08.10-10.10

Symposium 9: Stromal cell-matrix interactions

   

LOMOND AUDITORIUM

   

Chair: G Williams (London, UK)

S38

08.10

Role of heparan sulphates in neuronal stem cell differentiation

   

J Turnbull (Liverpool, UK)

S39

08.40

Hormonal regulation of mesenchymal stem cell differentiation in bone

   

F Jakob (Würzburg, Germany)

S40

09.10

Cell adhesion molecules and osteoclast function

   

M Helfrich (Aberdeen, UK)

S41

09.40

Wnt signalling in the stem cell niche

   

A Clark (Cardiff, UK)

     
 

08.10-10.10

Symposium 10: Controversies in male health

    Generously supported by Ipsen
   

CLYDE AUDITORIUM

   

Chair: M Maggi (Florence, Italy)

S42

08.10

Does andropause exist?

   

A Perheentupa (Turku, Finland)

S43

08.40

Cardiovascular effects of androgens

   

F Wu (Manchester, UK)

S44

09.10

Endocrine regulation of prostatic growth

   

Z Culig (Innsbruck, Austria)

S45

09.40

Stem cell therapeutic approaches to male infertility

   

S Schlatt (Pittsburgh, USA)

     
 

08.10-10.10

Oral Communications 5: Neuroendocrinology and neoplasia

   

FORTH ROOM

   

Chairs: S Tsagarakis (Athens, Greece) & I Gerendai (Budapest, Hungary)

OC33

08.10

Effect of overexpression of GH secretagogue receptor (GHSR) in the pituitary of transgenic mice

   

LM Seoane, D Carmignac, FF Casanueva & ICAF Robinson

OC34

08.25

Transgenic mice overexpressing urocortin 3 show increased anxiety and depressive like behaviours but a hyporesponsive ACTH response to stress

   

P M Jamieson, A Chen & W Vale

OC35

08.40

Immunocytochemical colocalisation of hormones in the human fetal pituitary

   

ARM Chirculescu, C Badiu, JF Morris & M Coculescu

OC36

08.55

Somatostatin analogues in the treatment of acromegaly: correlation between somatostatin receptor subtype expression levels and clinical response

   

S Petersenn, A Redmann, DK Luedecke & K Mann

OC37

09.10

90Y-dotatate in the treatment of neuroendocrine tumours

   

D Handkiewicz-Junak, K Hasse-Lazar, B Jurecka-Lubieniecka, J Krajewska, J Roskosz, A Kukulska, S Szpak, A Krawczyk & B Jarzab

OC38

09.25

Germline mutations in patients with apparently sporadic pheochromocytomas/ paragangliomas

   

M Mannelli, MS Gaglianò, L Simi, T Ercolino, L Becherini, P Pinzani, R Sestini, GP Bernini, M Mascalchi & M Genuardi

OC39

09.40

11b-hydroxysteroid dehydrogense modulation of HPA function - importance of genetic background

   

RN Carter, U Tworowska, JR Seckl & MC Holmes

OC40

09.55

Expression of IGF-I and IGF-IR in tamoxifen-sensitive and tamoxifenresistant breast cancer

   

CJ McVittie, S Khalaf, W Ogunkolade, R Carpenter, SA Bustin & PJ Jenkins

     
 

08.10-10.10

Nurses Session: Metabolic syndrome

   

ALSH ROOM

   

Chairs: D Greenfield (Sheffield, UK) & S Shalet (Manchester, UK)

S97

08.10

Leptin expands function

   

H Randeva (Coventry, UK)

S98

08.35

Ghrelin update

   

V Popovic (Belgrade, Serbia and Montenegro)

S99

09.00

Insulin resistance and type 2 diabetes - insights from the study of extreme human phenotypes

   

D Savage (Cambridge, UK)

S100

09.25

Metabolic syndrome

   

N Finer (Cambridge, UK)

S101

09.50

Nurse-led weight management: the Counterweight Programme

   

L McCombie (Glasgow, UK)

     
 

10.10-10.40

COFFEE

   

HALL 3

     
 

10.40-11.25

British Thyroid Association Pitt-Rivers Lecture

   

CLYDE AUDITORIUM

   

Chair: A Weetman (Sheffield, UK)

S5

10.40

Neurological abnormalities in mice with a dominant negative thyroid hormone a1

   

B Vennström (Stockholm, Sweden)

     
 

11.35-12.20

Meet the Expert 9: Medical management of Cushing's disease

   

CLYDE AUDITORIUM

   

Chair: J Newell Price (Sheffield, UK)

   

G Chrousos (Athens, Greece)

     
 

11.35-12.20

Meet the Expert 10: Graves' ophthalmopathy

   

LOMOND AUDITORIUM

   

Chair: P Perros (Newcastle upon Tyne, UK)

   

W Wiersinga (Amsterdam, The Netherlands)

     
 

11.35-12.20

Meet the Expert 11: Metabolic, functional and oncologic consequences of altered GH/IGF expression

   

HALL 1

   

Chair: G Brockman (Berlin, Germany)

   

P Jenkins (London, UK)

     
 

11.35-12.20

Meet the Expert 12: Growth hormone deficiency in adults

   

FORTH ROOM

   

Chair: D Johnston (London, UK)

   

E-M Erfurth (Uppsala, Sweden)

     
 

12.20-13.50

European Society of Endocrinology AGM

   

CLYDE AUDITORIUM followed by a drinks reception for attendees in the Gala Foyer

     
 

13.50-14.50

POSTERS AND LUNCH

   

HALL 3

     
 

14.50-16.50

Symposium 11: How hormones get into cells

   

CLYDE AUDITORIUM

   

Chair: K Chapman (Edinburgh, UK)

S46

14.50

Specific thyroid hormone transporters

   

T Visser (Rotterdam, The Netherlands)

S47

15.20

The spectrum of MCT8 gene mutations

   

H Krude (Berlin, Germany)

S48

15.50

Multidrug resistance p-glycoprotein (Mdr-1): excluding corticosteroids from brain

   

E de Kloet (Leiden, The Netherlands)

S49

16.20

Cell surface carrier-mediated transport of steroid hormones

   

J Steffgen (Biberach, Germany)

     
 

14.50-16.50

Symposium 12: Endocrinology in the fetus

   

HALL 1

   

Chair: TBA

S50

14.50

Maternal thyroid function and cognitive impairment in childhood

   

A van Wassenaer (Amsterdam, The Netherlands)

S51

15.20

Molecular basis of programming of renin-secreting cells

   

S Pennings (Edinburgh, UK)

S52

15.50

Birth weight and later disease: genes and maternal diabetes

   

R Lindsay (Glasgow, UK)

S53

16.20

Endocrine therapy of the fetus

   

A Grüters-Kieslich (Berlin, Germany)

     
 

14.50-16.50

Clinical Management Workshop 4: Contrasting practices in European endocrinology

   

LOMOND AUDITORIUM

   

Chair: B Allolio (Wurzburg, Germany)

S88/S89

14.50

Diagnosis of hypercortisolism

   

R Feelders (Rotterdam, The Netherlands) & A Atkinson (Belfast, UK)

S90/S91

15.30

New endocrinology medicines: S91 when are they good value?

   

A Walker (Glasgow, UK) & J Sandahl Christiansen (Aarhus, Denmark)

S92/S93

16.10

Contrasting practices in European S93 endocrinology - radio-iodine therapy

   

A Toft (Edinburgh, UK) & L Hegedüs (Odense, Denmark)

     
 

14.50-16.50

Oral Communications 6: Endocrine genetics

   

FORTH ROOM

   

Chairs: K Chatterjee (Cambridge, UK) & W de Herder (Rotterdam, The Netherlands)

OC41

14.50

Mutations in cullin 7, a cofactor for ubiquitination, cause the 3M intra-uterine growth retardation syndrome

   

PE Clayton, L O'Sullivan, A Glaser, MH Oliveira, MRS de Alacantara, ES de Almeida Barretto, H Kingston, A Read, V Cormier-Daire, PJ Scambler & G Black

OC42

15.05

Linkage of a fourth gene for familial glucocorticoid deficiency to chromosome 13q

   

LA Metherell, C Becker, F Ruschendorf, D Naville, M Begeot, P Nurnberg, A Huebner, MO Savage & AJL Clark

OC43

15.20

Mutation screening of SLC26A4 (PDS) gene in patients with Pendred syndrome and non-syndromic enlarged vestibular aqueduct

   

M Ladsous, V Vlaeminck-Guillem, C Vincent, F Dubrulle, V Dumur & JL Wémeau

OC44

15.35

Functional impact of polymorphic variation in the gene encoding 11b- hydroxylase (CYP11B1): reduced adrenal 11-hydroxylase efficiency identifies a key intermediate phenotype in hypertension

   

M Barr, E Friel, SM MacKenzie, CD Holloway, EM Freel, NJR Brain, DM Wilkinson, M Ingram, R Fraser, AF Dominiczak, JMC Connell & E Davies

OC45

15.50

Genotype/phenotype correlation of PRKAR1A mutations in patients with Carney complex (CNC) and/or sporadic primary pigmented nodular adrenocortical disease (PPNAD) from the CNC network

   

L Groussin, F Rene-Corail, L Cazabat, E Jullian, E Clauser, X Bertagna & J Bertherat

OC46

16.05

Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC-gene

   

HP Neumann

OC47

16.20

Frequent involvement of BMP15 gene variants in women with premature ovarian failure

   

E Di Pasquale, R Rossetti, A Marozzi, S Borgato, L Cavallo, F de Luca, S Einaudi, G Radetti, G Russo, M Sacco, P Beck-Peccoz & L Persani

OC48

16.25

Progressive osseous heteroplasia: a phenotype associated with mutations of the GNAS1 gene

   

N Richard, G Abeguile & ML Kottler

     
 

16.50-17.30

TEA

   

HALL 3

     
 

17.30-18.15

Society for Endocrinology Dale Medal Lecture

   

CLYDE AUDITORIUM

   

Chair: J Wass (Oxford, UK)

S6

17.30

The actions of inhibin in endocrine tissues

   

J Findlay (Clayton, Australia)

     
 

From 19.30

Congress Banquet and Ceilidh

   

HILTON HOTEL


return to top...

Sponsors
Gold Sponsors
Ipsen - Innovation for patient care (Logo)
Novartis (Logo)
Pfizer - Endocrine Care (Logo)
Bronze Sponsors
Lilly (logo)
Novo Nordisk (logo)
GSK Roche